Active Ingredient (In Each Capsule)
Loperamide HCl 2 mg
The following Structured Product Label (SPL) was submitted to the FDA by Rite Aid Corporation for the product Anti-diarrheal (NDC 11822-7834). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each capsule), purpose, use, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Loperamide HCl 2 mg
Anti-diarrheal
controls symptoms of diarrhea, including Travelers' Diarrhea
Allergy alert: Do not use if you have ever had a rash or other allergic reaction to loperamide HCl
Heart alert: Taking more than directed can cause serious heart problems or death
taking a prescription drug. Loperamide may interact with certain prescription drugs.
tiredness, drowsiness, or dizziness may occur. Be careful when driving or operating machinery.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
butylated hydroxyanisole, edible ink, FD&C Blue #1, gelatin, glycerin, glyceryl caprylate, polyoxyl 40 hydrogenated castor oil, purified water
call toll free 1-888-235-2466 (Mon - Fri 9AM - 5PM EST)
THIS PRODUCT IS PACKAGED IN A CHILD-RESISTANT AND TAMPER EVIDENT PACKAGE. USE ONLY IF BLISTERS ARE INTACT.
KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION.
†All trademarks are property of their respective owners. This product is not manufactured or distributed by the owners of Imodium ® A-D
DISTRIBUTED BY:
RITE AID, 30 HUNTER LANE,
CAMP HILL, PA 17011
www.riteaid.com
SATISFACTION GUARANTEE:
If you're not satisfied, we'll happily refund your money.
Lot #
Expiration Date
Rev # 03/21
L0000415
* Please review the disclaimer below.